Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA Docetaxel gCSI pan-cancer AAC 0.037 0.5
mRNA lenalidomide FIMM pan-cancer AAC 0.14 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA CI-976 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA linifanib CTRPv2 pan-cancer AAC 0.025 0.5
mRNA 5-FU CTRPv2 pan-cancer AAC -0.024 0.5
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC 0.049 0.5
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.05 0.5
Download CSV